170 related articles for article (PubMed ID: 9163805)
21. Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group.
Am J Kidney Dis; 1991 Jul; 18(1):50-9. PubMed ID: 2063855
[TBL] [Abstract][Full Text] [Related]
22. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin.
Beresford CH
N Z Med J; 1989 Apr; 102(866):185-6. PubMed ID: 2652007
[No Abstract] [Full Text] [Related]
24. Reasons for differences in dose requirements of recombinant human erythropoietin in haemodialysis patients.
Scigalla P; Messinger D; Wieczorek L
Contrib Nephrol; 1990; 82():55-64. PubMed ID: 2093527
[No Abstract] [Full Text] [Related]
25. Recombinant human erythropoietin: implications for nephrology.
Eschbach JW; Adamson JW
Am J Kidney Dis; 1988 Mar; 11(3):203-9. PubMed ID: 3278599
[TBL] [Abstract][Full Text] [Related]
26. Target haematocrit during erythropoietin treatment in dialysis patients. Which value is 'true-functional haematocrit'?
Vlassopoulos D; Sonikian M; Dardioti V; Hadjiconstantinou V
Nephrol Dial Transplant; 1999 May; 14(5):1340-1. PubMed ID: 10344405
[No Abstract] [Full Text] [Related]
27. Effects of withdrawing erythropoietin.
Taylor JE; Henderson IS; Mactier RA; Stewart WK
BMJ; 1991 Feb; 302(6771):272-3. PubMed ID: 1998794
[No Abstract] [Full Text] [Related]
28. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
[TBL] [Abstract][Full Text] [Related]
29. Side effects of erythropoietin therapy.
Bennett WM
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):84-6. PubMed ID: 1928085
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin: from molecular biology to clinical use.
Lacombe C
Eur Cytokine Netw; 1997 Sep; 8(3):308-10. PubMed ID: 9346370
[No Abstract] [Full Text] [Related]
31. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
[TBL] [Abstract][Full Text] [Related]
32. Evolution of anemia of chronic renal failure after the treatment of hyperparathyroidism.
Garcia-Canton C; Palomar R; Moreno A; Toledo A; Suria S; Esparza N; Rossique P; Checa MD
Nephron; 1996; 74(2):444-5. PubMed ID: 8893180
[No Abstract] [Full Text] [Related]
33. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
Romero González R; Torquet Escuder P
Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
[No Abstract] [Full Text] [Related]
34. Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation.
Am J Kidney Dis; 1989 Sep; 14(3):163-9. PubMed ID: 2672796
[No Abstract] [Full Text] [Related]
35. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
Eschbach JW; Haley NR; Adamson JW
Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
[No Abstract] [Full Text] [Related]
36. Erythropoietin therapy in peritoneal dialysis patients.
Morris AT; Ronco C
Perit Dial Int; 2000; 20 Suppl 2():S178-82. PubMed ID: 10911666
[No Abstract] [Full Text] [Related]
37. Anemia of renal failure. Use of erythropoietin.
Humphries JE
Med Clin North Am; 1992 May; 76(3):711-25. PubMed ID: 1578966
[TBL] [Abstract][Full Text] [Related]
38. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T
Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
[TBL] [Abstract][Full Text] [Related]
39. Daily self-administered subcutaneous erythropoietin: benefits in haemodialysis patients.
Granolleras C; Branger B; Deschodt G; Shaldon S; Nonnast-Daniel B; Pollok M
Contrib Nephrol; 1990; 82():49-54. PubMed ID: 2093526
[No Abstract] [Full Text] [Related]
40. Nutritional implications of recombinant human erythropoietin therapy in renal disease.
Sanders HN; Rabb HA; Bittle P; Ramirez G
J Am Diet Assoc; 1994 Sep; 94(9):1023-9. PubMed ID: 8071484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
